This federal contract award SPE2DB22D3501|SPE2DB25FTS74, valued at $11,391.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product REXULTI 2 MG TABLET 30S. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a firm fixed-price pricing type and a completion date of December 6, 2024. The contract does not have a set-aside designation, indicating open competition.
Generated 3/6/25, 9:44 AM